Managers / Q3 2020 · view latest →
Jacobsen Capital Management
CIK 0001782491 · 101 SOUTH 200 EAST, SUITE 524, SALT LAKE CITY, UT, 84111 · 801-746-7171
Summary
Jacobsen Capital Management reported $143M in U.S.-listed holdings across 58 positions for Q3 2020.
Its largest position, VTV, represents 14.7% of the portfolio.
Compared with Q2 2020, the fund opened 4 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 66.0% · $94M
- Common Stock · 30.1% · $43M
- REIT · 3.0% · $4M
- Other · 0.9% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| STERIS PLC | NEW | +7.7K | 7.7K | +$1M | $1M |
| MTCHMATCH GROUP INC NEW | NEW | +9.5K | 9.5K | +$1M | $1M |
| CTXSEURCITRIX SYS INC | NEW | +6.4K | 6.4K | +$882,000 | $882,000 |
| RTXRAYTHEON TECHNOLOGIES CORP | NEW | +9.8K | 9.8K | +$566,000 | $566,000 |
| AAPLAPPLE INC | ADDED | +19.1K | 27.9K | +$49,000 | $3M |
| MKLMARKEL CORP | ADDED | +708 | 1.1K | +$707,000 | $1M |
| GLOBAL X FDS | ADDED | +23.4K | 41.6K | +$602,000 | $1M |
| CVSCVS HEALTH CORP | SOLD OUT | −12.3K | 0 | −$801,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $296M | 124 | Apr 24, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $306M | 121 | Jan 26, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $295M | 121 | Oct 27, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $272M | 116 | Jul 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $230M | 100 | Apr 25, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $235M | 95 | Jan 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $238M | 102 | Oct 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $224M | 97 | Jul 23, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $216M | 92 | Apr 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $198M | 83 | Jan 24, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $184M | 73 | Oct 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $194M | 71 | Aug 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 70 | May 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 53 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $175M | 49 | Oct 25, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $188M | 55 | Aug 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $218M | 54 | Apr 21, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $211M | 53 | Feb 1, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $198M | 53 | Oct 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $196M | 54 | Jul 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $181M | 55 | Apr 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $169M | 57 | Feb 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $143M | 58 | Oct 22, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $131M | 57 | Aug 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $100M | 58 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $104M | 65 | Oct 21, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $100M | 61 | Aug 2, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.